Dive Brief:
- Rush University System for Health and Endeavor Health have announced plans to merge, a deal that — if approved by regulators — would create one of the largest health systems in Illinois.
- The combined system would control 12 hospitals and 400 outpatient clinics backed by Rush’s respected academic medical reputation and Endeavor’s deep pockets, giving it a potential edge in the competitive Chicagoland market.
- Endeavor plans to fund a $1 billion investment as part of the deal, which will be funneled into research, community care, and quality and innovation initiatives at the combined system, according to a joint release on Wednesday. The transaction is expected to close early 2027 subject to regulatory review.
Dive Insight:
Rush and Endeavor presented the merger as a marriage of equals. Endeavor is providing a sizable infusion of cash to bolster key initiatives and taking the reins of the C-suite, with current CEO J.P. Gallagher tapped to serve as president and CEO of the combined system.
However, the system will operate under the Rush name, given the brand’s “strong national reputation and position as a leading academic institution,” according to the release. Its board will be led by a chair from Rush, and include include 20 people comprised equally of representatives from Rush and Endeavor.
Chicago-based academic medical center Rush operates three hospitals in the area: Rush University Medical Center in Chicago, Rush Oak Park Hospital in Oak Park and Rush Copley Medical Center in Aurora. Its flagship medical center has been frequently named one of the top hospitals in the country, and has a reputation for technological innovation along with high-quality care.
Endeavor, formed in 2022 from the merger of North Shore University Health System and Edward-Elmhurst Healthcare, is the third-largest system in Illinois, with nine hospitals in the northeast.
Hospital mergers are picking up, driven by smaller operators looking for larger partners to help them weather today’s difficult operating environment, and by stable systems seeking to strengthen their competitive advantage.
The proposed deal between Endeavor and Rush reads as the latter. Neither system is struggling financially — Endeavor brought in more than $663 million in net income during its most recent fiscal year, according to Becker’s Hospital Review. That’s up from a loss the year prior when the system was hit with legal costs. Meanwhile, Rush brought in $294 million in net income in the twelve months ended June 30, up 57% year over year.
Instead, the merger appears to be a bid for scale in a competitive metropolitan area. Chicago has a high volume of providers jockeying for patient volume and market share — including many academic medical giants, like Northwestern Medicine, University of Chicago Medicine and Advocate Health — but no dominant player.
Rush’s market position has been “comparatively weaker” than its academic medical peers, given “competition in the Chicago area remains robust,” Fitch Ratings wrote when reaffirming Rush’s bond rating late last year.
Joining with Endeavor could help Rush leapfrog the competition. Together, the combined system will have more than 46,000 employees and clinicians serving more than 2 million patients each year in Northern Illinois and Northwest Indiana, according to the release.
“The system will aim to excel as the region’s first-choice healthcare provider and employer,” the release says.
